ArticleFrontiers in immunology2023

Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents.

Zheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.